Balchem (BCPC) Tops Q1 EPS by 1c, CEO Comments on Outlook
Balchem Corporation (Nasdaq: BCPC) reports Q1 EPS of $0.25, 1 cent better than estimates.
Revenues were $56.9 million. This is an increase of 106% above the $27.6 million result of the prior year comparable quarter and was derived from both organic and acquisition growth.
Commenting on 2008, Dino A. Rossi, President and CEO of Balchem said, "We continue to see improved results of our calcium products for the pharmaceutical and OTC markets, with a couple of new calcium product launches scheduled for the second quarter. The Animal Nutrition and Health segment is realizing excellent global revenue growth in both the specialty and basic choline product lines. Our pharmaceutical research efforts will continue to generate milestone payments throughout the balance of the year. We expect 2008 to be another year of continuing quality double digit improvements in sales and earnings, as we leverage our production capacity and business infrastructure.''
Balchem Corporation (Balchem) is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. [SM]
Revenues were $56.9 million. This is an increase of 106% above the $27.6 million result of the prior year comparable quarter and was derived from both organic and acquisition growth.
Commenting on 2008, Dino A. Rossi, President and CEO of Balchem said, "We continue to see improved results of our calcium products for the pharmaceutical and OTC markets, with a couple of new calcium product launches scheduled for the second quarter. The Animal Nutrition and Health segment is realizing excellent global revenue growth in both the specialty and basic choline product lines. Our pharmaceutical research efforts will continue to generate milestone payments throughout the balance of the year. We expect 2008 to be another year of continuing quality double digit improvements in sales and earnings, as we leverage our production capacity and business infrastructure.''
Balchem Corporation (Balchem) is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. [SM]
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
